Extra Damages Bid In $22M Stent Suit Denied By Fed. Circ.
The Federal Circuit on Monday denied a bid by Spectralytics Inc. to add more than $500,000 in enhanced damages to the $22 million verdict it won in a patent infringement suit...To view the full article, register now.
Already a subscriber? Click here to view full article